
NDI-034858
CAS No. 2272904-53-5
NDI-034858( —— )
Catalog No. M35681 CAS No. 2272904-53-5
NDI-034858 (TAK-279) is a tyrosine kinase 2 (TYK2) inhibitor (Kd<200 pM) that targets the JH2 structural domain of Tyk2 for the treatment of autoimmune diseases caused by aberrant expression of IL12 and IL23.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 400 | Get Quote |
![]() ![]() |
5MG | 749 | Get Quote |
![]() ![]() |
10MG | 1197 | Get Quote |
![]() ![]() |
25MG | 1720 | Get Quote |
![]() ![]() |
50MG | 2328 | Get Quote |
![]() ![]() |
100MG | 3051 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameNDI-034858
-
NoteResearch use only, not for human use.
-
Brief DescriptionNDI-034858 (TAK-279) is a tyrosine kinase 2 (TYK2) inhibitor (Kd<200 pM) that targets the JH2 structural domain of Tyk2 for the treatment of autoimmune diseases caused by aberrant expression of IL12 and IL23.
-
DescriptionZasocitinib (NDI-034858) is a TYK2 inhibitor, target TYK2 JH2 domain with binding constant Kd of <200 pM.
-
In VitroZasocitinib (10 μM) exhibits inhibitory effect on Tyk2 and JAK by targeting Tyk2 JH1 and JAK JH1 domain with inhibition rates <50%, respectively.Zasocitinib inhibits phosphorylation induction of heterodimer complex Tyk2 /JAK2-mediated IL-12 (1.7 ng/mL) effect, with IC50 value of <0.1 μM in human peripheral blood mononuclear cell.
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosine Kinases | IL Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2272904-53-5
-
Formula Weight460.49
-
Molecular FormulaC23H24N8O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (108.58 mM; Ultrasonic (<60°C)
-
SMILESCNc1cc(Nc2cccn(-c3ccccn3)c2=O)nc2c(cnn12)C(=O)N[C@@H]1CC[C@H]1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Masse, Craig E, et al. Pyrazolopyrimidines as TYK2 inhibitors and their preparation: World Intellectual Property Organization, WO2019023468. 2019-01-31.
molnova catalog



related products
-
GTP-14564
GTP-14564 is a novel tyrosine kinase inhibitor that also inhibits wt-FLT3 and ITD-FLT3.
-
Oxyresveratrol 3-O-β...
Oxyresveratrol 3'-O-β-D-glucopyranoside is a phenolic compound isolated from Morus nigra root and is an effective tyrosinase inhibitor with an IC50 of 1.64 μM.
-
Methyl cinnamate
Methyl cinnamate a tyrosinase inhibitor and a flavoring compound has antimicrobial antiadipogenic vasorelaxant and anti-inflammatory effects.